Table 2.
Validation of Multiplexed-Assay
Gene | EGFP gaina | Cell viabilityb | Gene knockdownc | Reference |
---|---|---|---|---|
EIF2C2 (Ago2) | 2/3 siRNA | No effect | 2/3 siRNA | 12 |
DGCR8 | 3/3 siRNA | 1/3 siRNA toxic | 1/3 siRNA | 9 |
DROSHA (RNASEN) | 2/3 siRNA | 1/3 siRNA toxic | 3/3 siRNA | 7,8 |
TNRC6B | 1/3 siRNA | No effect | 3/3 siRNA | 31 |
DICER1 | 2/3 siRNA | 2/3 siRNA toxic | 3/3 siRNA | 11 |
TARBP2 | 1/3 siRNA | 1/3 siRNA toxic | 3/3 siRNA | 30 |
EIF2C1 (Ago1) | No gain | 1/3 siRNA toxic | 3/3 siRNA | 28 |
EIF2C3 (Ago3) | 2/3 siRNA | 1/3 siRNA toxic | 0/3 siRNA | 28 |
EIF2C4 (Ago4) | No gain | No effect | 2/3 siRNA | 28 |
TNRC6A | No gain | No effect | 2/3 siRNA | 31 |
TNRC6C | No gain | No effect | 2/3 siRNA | 31 |
DHX9 | No gain | 1/3 siRNA toxic | 3/3 siRNA | 27 |
XPO5 | No gain | No effect | 3/3 siRNA | 10 |
MOV10 | 1/3 siRNA | 1/3 siRNA toxic | 3/3 siRNA | 29 |
SCPEP1 | No gain | 1/3 siRNA toxic | 3/3 siRNA | 32 |
KIF11 | No gain | 3/3 siRNA toxic | 3/3 siRNA | 33 |
PLK1 | 1/3 siRNA | 3/3 siRNA toxic | 3/3 siRNA | 34 |
Number of siRNA for given gene resulting in >2σ EGFP fluorescence above background as determined by Silencer Select Negative Control #1 siRNA.
Number of siRNA resulting in cytotoxicity with >80% inhibition relative to data median.
Number of siRNA resulting in knockdown using a threshold of 40% gene expression remaining.